Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 438

1.

Antidepressants use in pediatric populations.

Gören JL.

Expert Opin Drug Saf. 2008 May;7(3):223-5. doi: 10.1517/14740338.7.3.223 .

PMID:
18462180
3.

Persisting decline in depression treatment after FDA warnings.

Libby AM, Orton HD, Valuck RJ.

Arch Gen Psychiatry. 2009 Jun;66(6):633-9. doi: 10.1001/archgenpsychiatry.2009.46.

PMID:
19487628
4.

Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.

Nemeroff CB, Kalali A, Keller MB, Charney DS, Lenderts SE, Cascade EF, Stephenson H, Schatzberg AF.

Arch Gen Psychiatry. 2007 Apr;64(4):466-72.

PMID:
17404123
5.

Antidepressants and suicidality: the basis of controversies.

Marcinko D.

Psychiatr Danub. 2007 Sep;19(3):238-40.

PMID:
17914327
6.

Pediatric prescribing practices and the FDA Black-box warning on antidepressants.

Cheung A, Sacks D, Dewa CS, Pong J, Levitt A.

J Dev Behav Pediatr. 2008 Jun;29(3):213-5. doi: 10.1097/DBP.0b013e31817bd7c9.

PMID:
18550990
7.
8.

Impact of the 2004 Food and Drug Administration pediatric suicidality warning on antidepressant and psychotherapy treatment for new-onset depression.

Valluri S, Zito JM, Safer DJ, Zuckerman IH, Mullins CD, Korelitz JJ.

Med Care. 2010 Nov;48(11):947-54. doi: 10.1097/MLR.0b013e3181ef9d2b.

PMID:
20856141
9.

Depression, antidepressants and suicidality: a critical appraisal.

Licinio J, Wong ML.

Nat Rev Drug Discov. 2005 Feb;4(2):165-71. Review.

PMID:
15688079
10.

The treatment of adolescent depression in the era of the black box warning.

Richmond TK, Rosen DS.

Curr Opin Pediatr. 2005 Aug;17(4):466-72. Review.

PMID:
16012257
11.

Suicidality in pediatric patients treated with antidepressant drugs.

Hammad TA, Laughren T, Racoosin J.

Arch Gen Psychiatry. 2006 Mar;63(3):332-9.

PMID:
16520440
12.

Pharmacotherapy of major depressive disorder in adolescents.

Masi G, Liboni F, Brovedani P.

Expert Opin Pharmacother. 2010 Feb;11(3):375-86. doi: 10.1517/14656560903527226. Review.

PMID:
20102303
13.

A black-box warning for antidepressants in children?

Newman TB.

N Engl J Med. 2004 Oct 14;351(16):1595-8. No abstract available.

PMID:
15483275
14.

Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults.

Katz LY, Kozyrskyj AL, Prior HJ, Enns MW, Cox BJ, Sareen J.

CMAJ. 2008 Apr 8;178(8):1005-11. doi: 10.1503/cmaj.071265. Erratum in: CMAJ. 2008 May 20;178(11):1466.

15.

The risks and benefits of antidepressant treatment for youth depression.

Bridge JA, Salary CB, Birmaher B, Asare AG, Brent DA.

Ann Med. 2005;37(6):404-12. Review.

PMID:
16203613
16.

[SSRIs (selective serotonin reuptake inhibitors) and suicidality in adults, adolescents and children].

Tandt H, Audenaert K, van Heeringen C.

Tijdschr Psychiatr. 2009;51(6):387-93. Review. Dutch.

17.

[Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].

Hjalmarsson L, Corcos M, Jeammet P.

Encephale. 2005 May-Jun;31(3):309-16. French.

PMID:
16142045
18.
19.
20.

Antidepressant-induced suicidality: an update.

Reeves RR, Ladner ME.

CNS Neurosci Ther. 2010 Aug;16(4):227-34. doi: 10.1111/j.1755-5949.2010.00160.x. Epub 2010 Apr 16. Review.

PMID:
20553304

Supplemental Content

Support Center